bpc-157 adverse effects human case report Is BPC‑157 a Risk? Safety, Side Effects, and Concerns Explained The Hidden Risks of BPC‑157:

Our AI-powered platform offers free, comprehensive doctor visits that are tailored to your unique health profile and remember every detail of your medical history

In a 1992 study in rats, the major finding was that intraperitoneal DSIP injection increased the concentration of substance P a neurotransmitter positively correlated with the regulation of anxiety and mood15 in the hypothalamus, suggesting to the researchers that the peptide sharply decreases the classical manifestations of stress.16 Earlier studies in humans, namely a series of five trials published in 1983, came to similar conclusions, with better relaxation and apparently improved tolerance against psychic stress reported by the subjects.17 Its possible that the improved stress and anxiety markers were consequent to DSIP-associated sleep enhancements.18 Substance use recovery A study from 1984 published in European Neurology describes DSIPs potential use as a treatment for alcohol and opiate use disorders

Most cases involve some combination of both components

No credible research supporting these applications